This trial is conducted in Europe. The aim of the trial is to investigate the safety, tolerability, pharmacokinetics (exposure of the trial drug in the body) and pharmacodynamics (the effect of the investigated drug on the body) of NNC0215-0384 administered to subjects with moderate to severe rheumatoid arthritis (RA) concomitantly treated with methotrexate (MTX).
Read more: http://www.clinicaltrials.gov/ct2/show/NCT01955603?cond=%22Arthritis%22&lup_s=01/29/2014&lup_d=30
